# Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

> **NCT01716793** · PHASE2 · COMPLETED · sponsor: **Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias** · enrollment: 354 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **DRUG:** Ara-C
- **OTHER:** Autologous transplantation
- **OTHER:** Allogeneic HLA-identical sibling transplantation
- **OTHER:** CD34+ selection

## Key facts

- **NCT ID:** NCT01716793
- **Lead sponsor:** Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 1998-09
- **Final completion:** 2003-11
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716793, "Risk-adapted Therapy for Adult Acute Myeloid Leukemia.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01716793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*